Biotech Direct
LightNews LightNews
biotechdirect.bsky.social
Biotech Direct
@biotechdirect.bsky.social
19 followers 130 following 20 posts
At the intersection of innovation and opportunity, we focus on dynamic public markets within the biotech and life sciences sectors, where cutting-edge advancements meet the potential for substantial growth.

Substack: https://biotechdirect.substack.com
Posts Replies Media Videos
biotechdirect.bsky.social
Portfolio Update #1 - Portfolio as at 19 March 2025

open.substack.com/pub/biotechd...
Portfolio Update #1
Portfolio as at 19 March 2025
open.substack.com
March 19, 2025 at 10:26 PM
biotechdirect.bsky.social
Edgewise Therapeutics - $EWTX (Nasdaq)

open.substack.com/pub/biotechd...
Edgewise Therapeutics - $EWTX (Nasdaq)
Unique expertise and singular focus on muscle science to develop novel therapeutics for serious skeletal and cardiac muscle diseases.
open.substack.com
March 19, 2025 at 10:36 AM
biotechdirect.bsky.social
Also conveniently the amount he paid for it.
March 18, 2025 at 11:07 PM
biotechdirect.bsky.social
Appointment of Robert LaCaze as Chief Commercial Officer

www.businesswire.com/news/home/20...
Robert LaCaze, Innovative Growth-Driver in Oncology, Joins Summit Therapeutics as Chief Commercial Officer
Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that Robert LaCaze has joined Summit Therapeutics as Chief Commerc...
www.businesswire.com
March 18, 2025 at 3:28 AM